Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Agios Pharmaceuticals Inc. logo

Agios Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

24.54
 
USD
  
0.18
  
(0.72%)
Optionable: Yes  Market Cap: 1,358 M  90-day average vol: 344,878

Previous close: 24.36  Open: 24.43  Bid: 24.34  Ask: 24.81
52 week range    
21.07   
   31.87
Peers   
XNCR / 
EXEL / 
BMRN / 
PFE / 
GSK / 
Last updated: Thursday 28th September 2023
51
MarketXLS Rank
60
Value
38
Technical
55
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

AGIO Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccruedPreferredStockDividends4 M
Basic EPS from continuing operations-4.77-5.9-4.23
Basic EPS total-0.76-4.7426.55-4.23
Basic weighted shares outstanding15 M34 M37 M39 M47 M57 M60 M69 M60 M55 M
BasicDiscontinuousOperations0.0332.45
Cost of sales-72000.0-83000.0-135000.0-70000.0-1 M-1 M-3 M-2 M
Depreciation-1 M-1 M-3 M-6 M-6 M-7 M-8 M-9 M-9 M-8 M
DepreciationAndAmortization-1 M-1 M-3 M-6 M-6 M-7 M-8 M-9 M-9 M-8 M
Diluted EPS total-2.83-1.59-3.15-5.07-6.75-6.03-6.86-4.7426.55-4.23
Diluted normalized net income/share-4.77-5.9-4.23
Diluted weighted shares outstanding14 M34 M37 M39 M47 M57 M60 M69 M60 M55 M
DilutedDiscontinuousOperations0.0332.45
GainOnSaleOfBusiness7 M
GainOnSaleOfPPE128 M
GainOnSaleOfSecurity16000.0-261000.0
GeneralAndAdministrativeExpense10 M19 M36 M51 M-6 M-11 M
Gross operating profit26 M65 M59 M70 M43 M93 M117 M118 M500000.013 M
Income before tax-39 M-54 M-118 M-198 M-315 M-346 M-301 M-329 M-357 M-232 M
Income taxes579000.0-426000.0
Interest income55000.0203000.0968000.03 M6 M16 M15 M7 M836000.0141 M
MiscOtherSpecialCharges38 M32 M62 M14 M7 M
Net income from total operations-39 M-54 M-118 M-198 M-315 M-346 M-411 M-329 M-357 M-232 M
NetIncomeCommonStockholders-44 M-54 M-118 M-198 M-315 M-346 M-411 M-329 M-357 M-232 M
NetIncomeContinuousOperations-39 M-54 M-118 M-198 M-315 M-346 M-411 M-329 M-357 M-232 M
NetIncomeDiscontinuousOperations2 M1,961 M
NetIncomeFromOtherGainsLosses-18 M
NetNonOperatingInterestIncomeExpense55000.0203000.0968000.03 M6 M16 M15 M7 M836000.0141 M
Operating income-39 M-54 M-119 M-201 M-321 M-362 M-426 M-336 M-378 M-389 M
Operating income before depreciation (EBITDA)-37 M-52 M-114 M-192 M-308 M-343 M-288 M-308 M-331 M-214 M
OperatingExpense-64 M-119 M-178 M-271 M-364 M455 M543 M336 M378 M402 M
Other income net-16000.0261000.0-38 M-32 M-62 M-14 M-7 M
Other special charges-7 M-10 M
OtherGandA10 M19 M36 M51 M-6 M-11 M
OtherOperatingExpenses-364 M-457 M-15 M-15 M-15 M-15 M
OtherunderPreferredStockDividend4 M
PreferredStockDividends4 M
RentAndLandingFees10 M19 M36 M51 M-6 M-11 M
Research & development expense55 M100 M142 M220 M293 M341 M411 M221 M257 M280 M
ResearchExpense55 M100 M142 M220 M293 M341 M411 M221 M257 M280 M
SalariesAndWages-3 M-12 M-32 M-42 M-48 M-73 M-72 M-62 M-54 M-49 M
Selling Gen & administrative expense10 M19 M36 M51 M71 M114 M132 M115 M121 M122 M
SellingAndMarketingExpense71 M114 M132 M115 M121 M122 M
SellingExpense71 M114 M132 M115 M121 M122 M
Special income/charges7 M10 M
Total Income available for interest expense (EBIT)-39 M-54 M-118 M-198 M-315 M-346 M-301 M-329 M-357 M-232 M
Total common shares outstanding32 M37 M38 M42 M57 M58 M69 M70 M55 M55 M
Total net income-39 M-54 M-118 M-198 M-315 M-346 M-411 M-329 M-357 M-232 M
Total ordinary shares56 M56 M56 M56 M56 M56 M56 M56 M56 M56 M
Total revenues26 M65 M59 M70 M43 M94 M118 M121 M500000.014 M
TotalExpenses-65 M-120 M-178 M-271 M-364 M454 M542 M336 M378 M400 M
TotalRevenue26 M65 M59 M70 M43 M94 M118 M203 M500000.014 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and Templates.
Get started today